Market Overview:
The global etomidate injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of surgical procedures, rising demand for sedation and anaesthesia, and growing awareness about the benefits of etomidate injection. By type, the global etomidate injection market is segmented into 20mg/10ml and 40mg/20ml segments. The 20mg/10ml segment is expected to account for a larger share of the global etomidate injection market in 2018. By application, the hospital segment is expected to account for a larger share of the global etomidate injection market in 2018.
Product Definition:
An etomidate injection is a medication that is used to help reduce anxiety and produce a calming effect. It is also used as a sedative before surgery.
20mg/10ml:
20mg/10ml is a concentration used for inducing sleep in patients before surgery. It is also used as an anti-epileptic drug and to reduce the frequency of seizures in people suffering from epilepsy. The 20mg/10ml solution contains etomidate, which is an analog of the sedative agent called nitrous oxide. Etomidate has a lower risk of causing oxygen toxicity than most other general anesthesia solutions, including 40% compared to 60% or 80%.
40mg/20ml:
40mg/20ml is a generic name for etomidate used in the treatment of acute cardiac failure and to reduce the length of hospital stay. It works by decreasing myocardial contractility, which causes reduced Myocardial Performance (MP) and Cardiac output (CO).
The global market for 40mg/20ml was valued at USD 536 million in 2013.
Application Insights:
The hospital application segment led the global etomidate injection market in 2017 and is projected to witness significant growth over the forecast period. The rising number of hospital admissions for trauma cases across the globe is expected to drive demand for etomidate injection in hospitals, which, in turn, will fuel market growth. In addition, increasing awareness about treatment of life-threatening conditions through advanced medical care coupled with growing emphasis on reducing mortality rates after traumatic injuries are anticipated to further propel demand over the forecast period.
Etomidate injections are used as an induction agent before surgery or during anesthesia for patients who have suffered from severe head injuries or brain surgeries and need sedation before undergoing medical procedures. The recovery center application segment is expected to grow at a steady CAGR owing to increasing incidence of road accidents worldwide that lead onto traumatic brain injury (TBI).
Regional Analysis:
North America dominated the global market in 2017 owing to the rising prevalence of cancer and other diseases, increasing government initiatives, and high adoption of advanced technologies. Moreover, presence of major players in this region is also expected to drive regional market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to factors such as improving healthcare infrastructure & availability of cost-effective treatment options for patients suffering from cancer & other chronic diseases. In addition, growing medical tourism industry will also boost demand for etomidate injection in Asia Pacific during the forecast period.
Moreover, Middle East countries are experiencing economic development on account of low oil prices; however; political instability may hinder growth during 2018-2030 period.
Growth Factors:
- Increasing incidence of surgical procedures: The global Etomidate Injection market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of surgical procedures.
- Rising demand for sedatives and anesthetics: The growth in the Etomidate Injection market is also attributed to the rising demand for sedatives and anesthetics across the globe.
- Technological advancements in Etomidate Injection products: The introduction of technologically advanced Etomidate Injection products is expected to fuel the growth of this market during the forecast period.
- Growing geriatric population: The global geriatric population is growing at a rapid pace, which is anticipated to drive the demand for Etomidate Injection products over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Etomidate Injection Market Research Report
By Type
20mg/10ml, 40mg/20ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Pfizer, Athenex, AuroMedics, Zydus, American Regent, Hikma, Mylan, Par Sterile Products, Sagent, Jiangsu Hengrui Medicine, Jiagnsu Nhwa Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Etomidate Injection Market Report Segments:
The global Etomidate Injection market is segmented on the basis of:
Types
20mg/10ml, 40mg/20ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Athenex
- AuroMedics
- Zydus
- American Regent
- Hikma
- Mylan
- Par Sterile Products
- Sagent
- Jiangsu Hengrui Medicine
- Jiagnsu Nhwa Group
Highlights of The Etomidate Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20mg/10ml
- 40mg/20ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Etomidate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Etomidate injection is a medication used to sedate patients. It is given as an intravenous or intramuscular injection. Etomidate can be used in combination with other medications to help treat anesthesia during surgery or childbirth.
Some of the key players operating in the etomidate injection market are Pfizer, Athenex, AuroMedics, Zydus, American Regent, Hikma, Mylan, Par Sterile Products, Sagent, Jiangsu Hengrui Medicine, Jiagnsu Nhwa Group.
The etomidate injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Etomidate Injection Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Etomidate Injection Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Etomidate Injection Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Etomidate Injection Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Etomidate Injection Market Size & Forecast, 2020-2028 4.5.1 Etomidate Injection Market Size and Y-o-Y Growth 4.5.2 Etomidate Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20mg/10ml
5.2.2 40mg/20ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Etomidate Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Etomidate Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20mg/10ml
9.6.2 40mg/20ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20mg/10ml
10.6.2 40mg/20ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20mg/10ml
11.6.2 40mg/20ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20mg/10ml
12.6.2 40mg/20ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20mg/10ml
13.6.2 40mg/20ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Etomidate Injection Market: Competitive Dashboard
14.2 Global Etomidate Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Athenex
14.3.3 AuroMedics
14.3.4 Zydus
14.3.5 American Regent
14.3.6 Hikma
14.3.7 Mylan
14.3.8 Par Sterile Products
14.3.9 Sagent
14.3.10 Jiangsu Hengrui Medicine
14.3.11 Jiagnsu Nhwa Group